Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itzler

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Pediatrics|December 1, 2010
Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilizationCelia D C Christie, Newton D Duncan, Kirk A Thame, et al.
Vaccine|December 3, 2014
Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of ageXiaoming Li, Jane H Zhang, Robert F Betts, et al.
The New England Journal of Medicine|January 6, 2006
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccineTimo Vesikari, David O Matson, Penelope Dennehy, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Pediatrics|December 1, 2010
Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilizationCelia D C Christie, Newton D Duncan, Kirk A Thame, et al.
Vaccine|December 3, 2014
Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of ageXiaoming Li, Jane H Zhang, Robert F Betts, et al.
The New England Journal of Medicine|January 6, 2006
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccineTimo Vesikari, David O Matson, Penelope Dennehy, et al.
Pageof 5